SCHEMBL2858029

SCHEMBL2858029

CCCCc1ccc(C#Cc2ccc(CNCc3ccc(OCC(=O)O)cc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.54
ACACB O00763 6/20 0.48
S1PR1 P21453 3/20 0.48
S1PR3 Q99500 3/20 0.48
S1PR2 O95136 2/20 0.48
THRA P10827 1/20 0.48
THRB P10828 1/20 0.48
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
S1PR4 O95977 1/20 0.45
LMNA P02545 1/20 0.45
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4469874 0.99 FFAR1 (0.52) FFAR1ACACBS1PR1S1PR3S1PR2
SCHEMBL12626710 0.89 ACACB (0.47) ACACBALDH1A1LMNA
SCHEMBL12611895 0.85 ALDH1A1 (0.61) PPARGPPARAALDH1A1HPGDHSD17B10
SCHEMBL2851095 0.84 FFAR1 (0.59) FFAR1S1PR1S1PR3S1PR2PPARG
SCHEMBL1812949 0.82 ACACB (0.49) ACACBS1PR1S1PR3S1PR2S1PR4
SCHEMBL2858924 0.82 RARB (0.61) ACACBS1PR1S1PR3S1PR2ALDH1A1
Hydrochloric Acid SCHEMBL1817481 0.81 ACACB (0.48) ACACBS1PR1S1PR3S1PR2S1PR4
SCHEMBL1813162 0.81 FFAR1 (0.49) FFAR1THRATHRBPPARGPPARA
SCHEMBL2054507 0.81 PPARA (0.67) THRBPPARGPPARAALDH1A1HPGD
SCHEMBL1816630 0.81 PTGES (0.55) FFAR1ACACBTHRATHRBPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20090029903-A1 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors MERCK SERONO SA (CH) 2009-01-29 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
EP-1756081-A1 1,1'-(1,2-ETHYNEDIYL)BIS-BENZENE DERIVATIVES AS PTP 1-B INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2007-02-28 EP disclosed
WO-2005097773-A1 1,1’-(1,2-ETHYNEDIYL)BIS-BENZENE DERIVATIVES AS PTP 1-B INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029903-A1 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors PTPRS, PTPRZ1, PTP4A1 FFAR1 293/4885ACACB 178/4885S1PR1 3302/4885
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS FFAR1 91/4885ACACB 105/4885S1PR1 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.